SC
BIIB icon

Scotia Capital’s Biogen BIIB Stock Holding History

Scotia Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
+6,274
New +$1.16M ﹤0.01% 551
2023
Q1 		– Sell
-3,516
Closed -$974K – 789
2022
Q4 		$974K Buy
+3,516
New +$993K 0.01% 454
2018
Q1 		– Sell
-9,953
Closed -$3.17M – 704
2017
Q4 		$3.17M Buy
9,953
+1,001
+11% +$321K 0.04% 223
2017
Q3 		$2.8M Buy
+8,952
New +$2.65M 0.04% 235
2014
Q2 		– Sell
-936
Closed -$286K – 575
2014
Q1 		$286K Buy
+936
New +$297K 0.01% 484

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Scotia Capital's BIIB Position: Q1 2026 in Review

Scotia Capital opened a new position in Biogen (BIIB) in Q1 2026: 6,274 shares worth $1.15M. The stake represents ﹤0.01% of the portfolio and ranks #551 among its holdings. This is a return to the name: Scotia Capital previously reported a position in BIIB as recently as Q4 2022.

Scotia Capital first reported a position in BIIB in Q1 2014 and has held it in 5 quarters since. The position peaked at $3.17M in Q4 2017. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Scotia Capital held 6,274 shares of Biogen worth $1.15M as of Q1 2026.
  • Biogen was a new Scotia Capital position in Q1 2026.
  • Biogen made up ﹤0.01% of Scotia Capital's portfolio in Q1 2026, its #551 holding.
  • Scotia Capital first reported a position in Biogen in Q1 2014 and has held it in 5 quarters since.
  • Scotia Capital's Biogen position peaked at $3.17M in Q4 2017.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.